Assessment of quality outcomes for robotic pancreaticoduodenectomy: Identification of the learning curve

Brian A. Boone, Mazen Zenati, Melissa E. Hogg, Jennifer Steve, Arthur James Moser, David L. Bartlett, Herbert J. Zeh, Amer H. Zureikat

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

IMPORTANCE: Quality assessment is an important instrument to ensure optimal surgical outcomes, particularly during the adoption of new surgical technology. The use of the robotic platform for complex pancreatic resections, such as the pancreaticoduodenectomy, requires close monitoring of outcomes during its implementation phase to ensure patient safety is maintained and the learning curve identified. OBJECTIVE: To report the results of a quality analysis and learning curve during the implementation of robotic pancreaticoduodenectomy (RPD). DESIGN, SETTING, AND PARTICIPANTS: A retrospective review of a prospectively maintained database of 200 consecutive patients who underwent RPD in a large academic center from October 3, 2008, through March 1, 2014, was evaluated for important metrics of quality. Patients were analyzed in groups of 20 to minimize demographic differences and optimize the ability to detect statistically meaningful changes in performance. EXPOSURES: Robotic pancreaticoduodenectomy. MAIN OUTCOMES AND MEASURES: Optimization of perioperative outcome parameters. RESULTS: No statistical differences in mortality rates or major morbidity were noted during the study. Statistical improvements in estimated blood loss and conversions to open surgery occurred after 20 cases (600 mL vs 250 mL [P = .002] and 35.0% vs 3.3% [P < .001], respectively), incidence of pancreatic fistula after 40 cases (27.5% vs 14.4%; P = .04), and operative time after 80 cases (581 minutes vs 417 minutes [P < .001]). Complication rates, lengths of stay, and readmission rates showed continuous improvement that did not reach statistical significance. Outcomes for the last 120 cases (representing optimized metrics beyond the learning curve) included a mean operative time of 417 minutes, median estimated blood loss of 250 mL, a conversion rate of 3.3%, 90-day mortality of 3.3%, a clinically significant (grade B/C) pancreatic fistula rate of 6.9%, and a median length of stay of 9 days. CONCLUSIONS AND RELEVANCE: Continuous assessment of quality metrics allows for safe implementation of RPD. We identified several inflexion points corresponding to optimization of performance metrics for RPD that can be used as benchmarks for surgeons who are adopting this technology.

Original languageEnglish (US)
Pages (from-to)416-422
Number of pages7
JournalJAMA Surgery
Volume150
Issue number5
DOIs
StatePublished - May 1 2015
Externally publishedYes

Fingerprint

Pancreaticoduodenectomy
Learning Curve
Robotics
Outcome Assessment (Health Care)
Pancreatic Fistula
Operative Time
Length of Stay
Conversion to Open Surgery
Technology
Benchmarking
Aptitude
Mortality
Patient Safety
Demography
Databases
Morbidity
Incidence

ASJC Scopus subject areas

  • Surgery

Cite this

Boone, B. A., Zenati, M., Hogg, M. E., Steve, J., Moser, A. J., Bartlett, D. L., ... Zureikat, A. H. (2015). Assessment of quality outcomes for robotic pancreaticoduodenectomy: Identification of the learning curve. JAMA Surgery, 150(5), 416-422. https://doi.org/10.1001/jamasurg.2015.17

Assessment of quality outcomes for robotic pancreaticoduodenectomy : Identification of the learning curve. / Boone, Brian A.; Zenati, Mazen; Hogg, Melissa E.; Steve, Jennifer; Moser, Arthur James; Bartlett, David L.; Zeh, Herbert J.; Zureikat, Amer H.

In: JAMA Surgery, Vol. 150, No. 5, 01.05.2015, p. 416-422.

Research output: Contribution to journalArticle

Boone, BA, Zenati, M, Hogg, ME, Steve, J, Moser, AJ, Bartlett, DL, Zeh, HJ & Zureikat, AH 2015, 'Assessment of quality outcomes for robotic pancreaticoduodenectomy: Identification of the learning curve', JAMA Surgery, vol. 150, no. 5, pp. 416-422. https://doi.org/10.1001/jamasurg.2015.17
Boone, Brian A. ; Zenati, Mazen ; Hogg, Melissa E. ; Steve, Jennifer ; Moser, Arthur James ; Bartlett, David L. ; Zeh, Herbert J. ; Zureikat, Amer H. / Assessment of quality outcomes for robotic pancreaticoduodenectomy : Identification of the learning curve. In: JAMA Surgery. 2015 ; Vol. 150, No. 5. pp. 416-422.
@article{f6aefd46730f4eba907f77ddf88c9632,
title = "Assessment of quality outcomes for robotic pancreaticoduodenectomy: Identification of the learning curve",
abstract = "IMPORTANCE: Quality assessment is an important instrument to ensure optimal surgical outcomes, particularly during the adoption of new surgical technology. The use of the robotic platform for complex pancreatic resections, such as the pancreaticoduodenectomy, requires close monitoring of outcomes during its implementation phase to ensure patient safety is maintained and the learning curve identified. OBJECTIVE: To report the results of a quality analysis and learning curve during the implementation of robotic pancreaticoduodenectomy (RPD). DESIGN, SETTING, AND PARTICIPANTS: A retrospective review of a prospectively maintained database of 200 consecutive patients who underwent RPD in a large academic center from October 3, 2008, through March 1, 2014, was evaluated for important metrics of quality. Patients were analyzed in groups of 20 to minimize demographic differences and optimize the ability to detect statistically meaningful changes in performance. EXPOSURES: Robotic pancreaticoduodenectomy. MAIN OUTCOMES AND MEASURES: Optimization of perioperative outcome parameters. RESULTS: No statistical differences in mortality rates or major morbidity were noted during the study. Statistical improvements in estimated blood loss and conversions to open surgery occurred after 20 cases (600 mL vs 250 mL [P = .002] and 35.0{\%} vs 3.3{\%} [P < .001], respectively), incidence of pancreatic fistula after 40 cases (27.5{\%} vs 14.4{\%}; P = .04), and operative time after 80 cases (581 minutes vs 417 minutes [P < .001]). Complication rates, lengths of stay, and readmission rates showed continuous improvement that did not reach statistical significance. Outcomes for the last 120 cases (representing optimized metrics beyond the learning curve) included a mean operative time of 417 minutes, median estimated blood loss of 250 mL, a conversion rate of 3.3{\%}, 90-day mortality of 3.3{\%}, a clinically significant (grade B/C) pancreatic fistula rate of 6.9{\%}, and a median length of stay of 9 days. CONCLUSIONS AND RELEVANCE: Continuous assessment of quality metrics allows for safe implementation of RPD. We identified several inflexion points corresponding to optimization of performance metrics for RPD that can be used as benchmarks for surgeons who are adopting this technology.",
author = "Boone, {Brian A.} and Mazen Zenati and Hogg, {Melissa E.} and Jennifer Steve and Moser, {Arthur James} and Bartlett, {David L.} and Zeh, {Herbert J.} and Zureikat, {Amer H.}",
year = "2015",
month = "5",
day = "1",
doi = "10.1001/jamasurg.2015.17",
language = "English (US)",
volume = "150",
pages = "416--422",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Assessment of quality outcomes for robotic pancreaticoduodenectomy

T2 - Identification of the learning curve

AU - Boone, Brian A.

AU - Zenati, Mazen

AU - Hogg, Melissa E.

AU - Steve, Jennifer

AU - Moser, Arthur James

AU - Bartlett, David L.

AU - Zeh, Herbert J.

AU - Zureikat, Amer H.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - IMPORTANCE: Quality assessment is an important instrument to ensure optimal surgical outcomes, particularly during the adoption of new surgical technology. The use of the robotic platform for complex pancreatic resections, such as the pancreaticoduodenectomy, requires close monitoring of outcomes during its implementation phase to ensure patient safety is maintained and the learning curve identified. OBJECTIVE: To report the results of a quality analysis and learning curve during the implementation of robotic pancreaticoduodenectomy (RPD). DESIGN, SETTING, AND PARTICIPANTS: A retrospective review of a prospectively maintained database of 200 consecutive patients who underwent RPD in a large academic center from October 3, 2008, through March 1, 2014, was evaluated for important metrics of quality. Patients were analyzed in groups of 20 to minimize demographic differences and optimize the ability to detect statistically meaningful changes in performance. EXPOSURES: Robotic pancreaticoduodenectomy. MAIN OUTCOMES AND MEASURES: Optimization of perioperative outcome parameters. RESULTS: No statistical differences in mortality rates or major morbidity were noted during the study. Statistical improvements in estimated blood loss and conversions to open surgery occurred after 20 cases (600 mL vs 250 mL [P = .002] and 35.0% vs 3.3% [P < .001], respectively), incidence of pancreatic fistula after 40 cases (27.5% vs 14.4%; P = .04), and operative time after 80 cases (581 minutes vs 417 minutes [P < .001]). Complication rates, lengths of stay, and readmission rates showed continuous improvement that did not reach statistical significance. Outcomes for the last 120 cases (representing optimized metrics beyond the learning curve) included a mean operative time of 417 minutes, median estimated blood loss of 250 mL, a conversion rate of 3.3%, 90-day mortality of 3.3%, a clinically significant (grade B/C) pancreatic fistula rate of 6.9%, and a median length of stay of 9 days. CONCLUSIONS AND RELEVANCE: Continuous assessment of quality metrics allows for safe implementation of RPD. We identified several inflexion points corresponding to optimization of performance metrics for RPD that can be used as benchmarks for surgeons who are adopting this technology.

AB - IMPORTANCE: Quality assessment is an important instrument to ensure optimal surgical outcomes, particularly during the adoption of new surgical technology. The use of the robotic platform for complex pancreatic resections, such as the pancreaticoduodenectomy, requires close monitoring of outcomes during its implementation phase to ensure patient safety is maintained and the learning curve identified. OBJECTIVE: To report the results of a quality analysis and learning curve during the implementation of robotic pancreaticoduodenectomy (RPD). DESIGN, SETTING, AND PARTICIPANTS: A retrospective review of a prospectively maintained database of 200 consecutive patients who underwent RPD in a large academic center from October 3, 2008, through March 1, 2014, was evaluated for important metrics of quality. Patients were analyzed in groups of 20 to minimize demographic differences and optimize the ability to detect statistically meaningful changes in performance. EXPOSURES: Robotic pancreaticoduodenectomy. MAIN OUTCOMES AND MEASURES: Optimization of perioperative outcome parameters. RESULTS: No statistical differences in mortality rates or major morbidity were noted during the study. Statistical improvements in estimated blood loss and conversions to open surgery occurred after 20 cases (600 mL vs 250 mL [P = .002] and 35.0% vs 3.3% [P < .001], respectively), incidence of pancreatic fistula after 40 cases (27.5% vs 14.4%; P = .04), and operative time after 80 cases (581 minutes vs 417 minutes [P < .001]). Complication rates, lengths of stay, and readmission rates showed continuous improvement that did not reach statistical significance. Outcomes for the last 120 cases (representing optimized metrics beyond the learning curve) included a mean operative time of 417 minutes, median estimated blood loss of 250 mL, a conversion rate of 3.3%, 90-day mortality of 3.3%, a clinically significant (grade B/C) pancreatic fistula rate of 6.9%, and a median length of stay of 9 days. CONCLUSIONS AND RELEVANCE: Continuous assessment of quality metrics allows for safe implementation of RPD. We identified several inflexion points corresponding to optimization of performance metrics for RPD that can be used as benchmarks for surgeons who are adopting this technology.

UR - http://www.scopus.com/inward/record.url?scp=84929691781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929691781&partnerID=8YFLogxK

U2 - 10.1001/jamasurg.2015.17

DO - 10.1001/jamasurg.2015.17

M3 - Article

C2 - 25761143

AN - SCOPUS:84929691781

VL - 150

SP - 416

EP - 422

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 5

ER -